Table of Contents

company-logo

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.

Enorama Pharma Dividend Announcement

• Enorama Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Enorama Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Enorama Pharma Dividend History

Enorama Pharma Dividend Yield

Enorama Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Enorama Pharma stock? Use our calculator to estimate your expected dividend yield:

Enorama Pharma Financial Ratios

P/E ratio-4.44
PEG ratio0.49
P/B ratio4.75
ROE-169.54%
Payout ratio0.00%
Current ratio2.74
Quick ratio2.00
Cash Ratio1.58

Enorama Pharma Dividend FAQ

Does Enorama Pharma stock pay dividends?
Enorama Pharma does not currently pay dividends to its shareholders.
Has Enorama Pharma ever paid a dividend?
No, Enorama Pharma has no a history of paying dividends to its shareholders. Enorama Pharma is not known for its dividend payments.
Why doesn't Enorama Pharma pay dividends?
There are several potential reasons why Enorama Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Enorama Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Enorama Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Enorama Pharma a dividend aristocrat?
Enorama Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Enorama Pharma a dividend king?
Enorama Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Enorama Pharma a dividend stock?
No, Enorama Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Enorama Pharma stocks?
To buy Enorama Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Enorama Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.